Axial Therapeutics™ is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. The company is leveraging its expertise in the gut-brain axis and its unique drug development platform to advance novel therapies that have the potential to transform the treatment paradigm in neurodegenerative diseases.
Location: United States, Massachusetts, Waltham
Employees: 11-50
Total raised: $37.3M
Founded date: 2016
Investors 4
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| - | Reimagined... | reimagined... |
| - | Taiho Vent... | taihoventu... |
| - | OneVenture... | one-ventur... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 12.10.2021 | Series C | $37.3M | - | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 10.02.2022 | The second fund of UTokyo Innovation Platform Co. comes to f... | TOKYO, Feb. 10, 2022 /PRNewswire/ -- We are pleased to announce that a fund operated by UTokyo Innov... | en.prnasia... |
| 10.02.2022 | The second fund of UTokyo Innovation Platform Co. comes to f... | TOKYO, Feb. 9, 2022 /PRNewswire/ -- We are pleased to announce that a fund operated by UTokyo Innova... | marketscre... |
| 14.10.2021 | Nextdoor CEO Sarah Friar throws down a gauntlet to social me... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 14.10.2021 | Nextdoor CEO Sarah Friar throws down a gauntlet to social me... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| - | Investors have poured $548 million into neuroscience biotech... | Peter Anastasiou, the CEO of Capsida Biotherapeutics. Capsida Biotherapeutics This story is availabl... | businessin... |
| - | Axial Therapeutics Promotes A. Stewart Campbell to Chief Exe... | WOBURN, Mass.--(BUSINESS WIRE)--Mar 8, 2021-- Axial Therapeutics Inc., a clinical-stage biopharmace... | oaoa.com/n... |